Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Lorraine J Gudas
Affiliation
Meyer Cancer Center
ORCID
Career Start Year
1974
Papers
280
H Index
67
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36733939
Clinical and molecular significance of the RNA m<sup>6</sup>A methyltransferase complex in prostate cancer.
Front Genet
2023
37569418
Retinoic Acid Receptor β Loss in Hepatocytes Increases Steatosis and Elevates the Integrated Stress Response in Alcohol-Associated Liver Disease.
Int J Mol Sci
2023
37217526
Novel genetically engineered mouse models for clear cell renal cell carcinoma.
Sci Rep
2023
37152294
The KDM5B and KDM1A lysine demethylases cooperate in regulating androgen receptor expression and signalling in prostate cancer.
Front Cell Dev Biol
2023
37331524
Vitamin A and retinoid signaling in the kidneys.
Pharmacol Ther
2023
36820942
Transcriptomic analysis predicts the risk of progression of premalignant lesions in human tongue.
Discov Oncol
2023
36722045
NDUFA4L2 reduces mitochondrial respiration resulting in defective lysosomal trafficking in clear cell renal cell carcinoma.
Cancer Biol Ther
2023
34687254
A retinoic acid receptor β2 agonist protects against alcohol liver disease and modulates hepatic expression of canonical retinoid metabolism genes.
Biofactors
2022
35551126
Fenretinide Reduces Intestinal Mucin-2-Positive Goblet Cells in Chronic Alcohol Abuse.
Pharmacology
2022
35406069
Retinoids in the Pathogenesis and Treatment of Liver Diseases.
Nutrients
2022
35726553
Transcriptional and metabolic remodeling in clear cell renal cell carcinoma caused by ATF4 activation and the integrated stress response (ISR).
Mol Carcinog
2022
35900851
Retinoid metabolism: new insights.
J Mol Endocrinol
2022
36263323
Exploring anti-androgen therapies in hormone dependent prostate cancer and new therapeutic routes for castration resistant prostate cancer.
Front Endocrinol (Lausanne)
2022
36291932
The METTL3 RNA Methyltransferase Regulates Transcriptional Networks in Prostate Cancer.
Cancers (Basel)
2022
35046813
Kidney-Targeted Redox Scavenger Therapy Prevents Cisplatin-Induced Acute Kidney Injury.
Front Pharmacol
2022
35130553
Pancreatic Ductal Adenocarcinoma: New Insights into the Actions of Vitamin A.
Oncol Res Treat
2022
35280824
All-<i>Trans</i>-Retinoic Acid Combined With Valproic Acid Can Promote Differentiation in Myeloid Leukemia Cells by an Autophagy Dependent Mechanism.
Front Oncol
2022
35231161
The genomic landscape of metastatic clear cell renal cell carcinoma after systemic therapy.
Mol Oncol
2022
34516292
Synthetic Retinoids Beyond Cancer Therapy.
Annu Rev Pharmacol Toxicol
2022
33068139
The Effect of Ethanol Consumption on Composition and Morphology of Femur Cortical Bone in Wild-Type and ALDH2*2-Homozygous Mice.
Calcif Tissue Int
2021
33815111
Fenretinide Improves Intestinal Barrier Function and Mitigates Alcohol Liver Disease.
Front Pharmacol
2021
34970493
Mitochondrial Ndufa4l2 Enhances Deposition of Lipids and Expression of Ca9 in the TRACK Model of Early Clear Cell Renal Cell Carcinoma.
Front Oncol
2021
34614148
EZH2 knockout in oral cavity basal epithelia causes more invasive squamous cell carcinomas.
Carcinogenesis
2021
34688661
A retinoic acid receptor β2 agonist attenuates transcriptome and metabolome changes underlying nonalcohol-associated fatty liver disease.
J Biol Chem
2021
34389654
A Retinoic Acid Receptor <i>β</i> <sub>2</sub> Agonist Improves Cardiac Function in a Heart Failure Model.
J Pharmacol Exp Ther
2021
32115621
Mutations in long-lived epithelial stem cells and their clonal progeny in pre-malignant lesions and in oral squamous cell carcinoma.
Carcinogenesis
2020
31846616
Modification of stem cell states by alcohol and acetaldehyde.
Chem Biol Interact
2020
31811682
All-trans retinoic acid (ATRA)-induced TFEB expression is required for myeloid differentiation in acute promyelocytic leukemia (APL).
Eur J Haematol
2020
31898184
NCI 6896: a phase I trial of vorinostat (SAHA) and isotretinoin (13-cis retinoic acid) in the treatment of patients with advanced renal cell carcinoma.
Invest New Drugs
2020
31865180
Combined Metabolomics and Genome-Wide Transcriptomics Analyses Show Multiple HIF1α-Induced Changes in Lipid Metabolism in Early Stage Clear Cell Renal Cell Carcinoma.
Transl Oncol
2020
31953251
Correction: An alternative retinoic acid-responsive <i>Stra6</i> promoter regulated in response to retinol deficiency.
J Biol Chem
2020
32037955
Doxycycline-induced exogenous Bmi-1 expression enhances tumor formation in a murine model of oral squamous cell carcinoma.
Cancer Biol Ther
2020
31820845
Inhibition of UBE2L6 attenuates ISGylation and impedes ATRA-induced differentiation of leukemic cells.
Mol Oncol
2020
32768676
Mycobacterium tuberculosis infection is exacerbated in mice lacking lecithin:retinol acyltransferase.
Biochim Biophys Acta Mol Basis Dis
2020
30677086
Effects of AM80 compared to AC261066 in a high fat diet mouse model of liver disease.
PLoS One
2019
31815952
Validation of risk factors for recurrence of renal cell carcinoma: Results from a large single-institution series.
PLoS One
2019
31359387
Lentiviral-Mediated shRNA Approaches: Applications in Cellular Differentiation and Autophagy.
Methods Mol Biol
2019
31283017
Different Effects of Knockouts in ALDH2 and ACSS2 on Embryonic Stem Cell Differentiation.
Alcohol Clin Exp Res
2019
30737277
Ethanol promotes differentiation of embryonic stem cells through retinoic acid receptor-γ.
J Biol Chem
2019
30978209
Retinoids induce antagonism between FOXO3A and FOXM1 transcription factors in human oral squamous cell carcinoma (OSCC) cells.
PLoS One
2019
29468550
Detection of E2F-DNA Complexes Using Chromatin Immunoprecipitation Assays.
Methods Mol Biol
2018
30054312
Amelioration of Diabetic Nephropathy Using a Retinoic Acid Receptor <i>β</i>2 Agonist.
J Pharmacol Exp Ther
2018
30153436
CARM1 (PRMT4) Acts as a Transcriptional Coactivator during Retinoic Acid-Induced Embryonic Stem Cell Differentiation.
J Mol Biol
2018
29907698
A Retinoic Acid <i>β</i><sub>2</sub>-Receptor Agonist Exerts Cardioprotective Effects.
J Pharmacol Exp Ther
2018
29875323
RIPK3 promotes sepsis-induced acute kidney injury via mitochondrial dysfunction.
JCI Insight
2018
29848550
Combinatorial knockout of RARα, RARβ, and RARγ completely abrogates transcriptional responses to retinoic acid in murine embryonic stem cells.
J Biol Chem
2018
26783287
Role of NADH Dehydrogenase (Ubiquinone) 1 Alpha Subcomplex 4-Like 2 in Clear Cell Renal Cell Carcinoma.
Clin Cancer Res
2016
26462866
Retinoic acid receptor β2 agonists restore glycaemic control in diabetes and reduce steatosis.
Diabetes Obes Metab
2016
26431912
The Tale of Two Hypoxia-Inducible Factors in Renal Cell Carcinoma.
Eur Urol
2016
27271256
A retinoic acid receptor β2 agonist reduces hepatic stellate cell activation in nonalcoholic fatty liver disease.
J Mol Med (Berl)
2016
1 - 50 of 280
Column Actions
Search
Recommended Authors
Sumedha Gunewardena
University of Kansas Medical Center
Career Start Year
2006
Number of shared co-authors
0
Yuelin J Zhu
National Cancer Institute, National Institutes of Health
Career Start Year
2002
Number of shared co-authors
0
Bingbing Yuan
Whitehead Institute for Biomedical Research
Career Start Year
2000
Number of shared co-authors
0
Po-Lin So
Gladstone Institutes
Career Start Year
1999
Number of shared co-authors
0
Robert L Walker
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year
1997
Number of shared co-authors
0
Julien Sage
Department of Pediatrics Stanford University Stanford California USA.
Career Start Year
1993
Number of shared co-authors
0
Sanja Pajovic
Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children
Career Start Year
1993
Number of shared co-authors
0
Ping Wei
Fudan University Shanghai Cancer Center
Career Start Year
1993
Number of shared co-authors
0
Rod Bremner
University of Toronto
Career Start Year
1990
Number of shared co-authors
0
Kristian Helin
The Institute of Cancer Research
Career Start Year
1988
Number of shared co-authors
0
Eldad Zacksenhaus
University of Toronto
Career Start Year
1988
Number of shared co-authors
1
Yoshiaki Ito
Tokyo Medical and Dental University (TMDU)
Career Start Year
1987
Number of shared co-authors
0
Martin J Walsh
Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Career Start Year
1987
Number of shared co-authors
0
Timothy C Burn
Incyte Research Institute
Career Start Year
1987
Number of shared co-authors
0
Klaus H Kaestner
Department of Genetics and Institute for Diabetes, University of Pennsylvania
Career Start Year
1986
Number of shared co-authors
0
Frederick E Domann
University of Iowa
Career Start Year
1986
Number of shared co-authors
0
Haruhiko Koseki
RIKEN Research Center for Allergy and Immunology
Career Start Year
1986
Number of shared co-authors
0
Joseph Torchia
Western University
Career Start Year
1985
Number of shared co-authors
0
Hans Clevers
Princess Maxima Center for Pediatric Oncology
Career Start Year
1985
Number of shared co-authors
6
Lesley M Forrester
Institute of Regeneration and Repair, The University of Edinburgh
Career Start Year
1984
Number of shared co-authors
1
Hugues de Th??
Universite Paris Cite, Inserm, CNRS, Institut de Recherche Saint-Louis
Career Start Year
1983
Number of shared co-authors
0
Roseline Godbout
University of Alberta
Career Start Year
1981
Number of shared co-authors
0
Craig R Tomlinson
Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth
Career Start Year
1980
Number of shared co-authors
0
Ann M Flenniken
Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital
Career Start Year
1980
Number of shared co-authors
0
Richard L Maas
Brigham and Women's Hospital, Harvard Medical School
Career Start Year
1980
Number of shared co-authors
0
Glenn Merlino
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year
1978
Number of shared co-authors
0
Bruce J Aronow
Cincinnati Children's Hospital Medical Center
Career Start Year
1975
Number of shared co-authors
1
Anton M Jetten
National Institutes of Health
Career Start Year
1972
Number of shared co-authors
0
J. Carl Barrett
Oncology R&D
Career Start Year
1966
Number of shared co-authors
1
Mario R Capecchi
University of Utah School of Medicine
Career Start Year
1965
Number of shared co-authors
0
row(s) 1 - 30 of 30
Collaborators
David M Nanus
Sandra and Edward Meyer Cancer Center
Co-authored papers
28
Tuo Zhang
Weill Cornell Medical College.
Co-authored papers
10
Brian D Robinson
Sandra and Edward Meyer Cancer Center
Co-authored papers
9
Douglas S Scherr
New York-Presbyterian Hospital
Co-authored papers
8
Johannes C van der Mijn
New York Presbyterian Hospital
Co-authored papers
7
Dean Bok
Co-authored papers
6
Ana M Molina
Englander Institute for Precision Medicine
Co-authored papers
4
Reshma Taneja
Co-authored papers
3
Adrian L Harris
University of Oxford
Co-authored papers
3
Beatrice S Knudsen
University of Utah
Co-authored papers
2
Andrea Sboner
Institute for Computational Biomedicine
Co-authored papers
2
Agnes Viale
Memorial Sloan Kettering Cancer Center
Co-authored papers
2
Clara Oromendia
Weill Cornell Medical College
Co-authored papers
2
Mark Mercola
Co-authored papers
2
Scott T Tagawa
Meyer Cancer Center, Weill Cornell Medicine-NewYork Presbyterian Hospital
Co-authored papers
2
Dora Dias-Santagata
Co-authored papers
2
Christopher Y Park
NYU Robert I. Grossman School of Medicine
Co-authored papers
1
Cora N Sternberg
Meyer Cancer Center, Englander Institute for Precision Medicine
Co-authored papers
1
Pooja Chandra
Weill Cornell Medical College
Co-authored papers
1
Alan R Tall
Co-authored papers
1
Mark A Rubin
University of Bern
Co-authored papers
1
Olivier Elemento
Meyer Cancer Center
Co-authored papers
1
Laszlo Nagy
University of Debrecen
Co-authored papers
1
Himisha Beltran
Dana-Farber Cancer Institute
Co-authored papers
1
Elisa de Stanchina
Co-authored papers
1
Alexandros Sigaras
Columbia University, United States Bureau of Educational and Cultural Affairs Fulbright Program, University of Piraeus, Weill Cornell Medical College, Weill Cornell Medicine
Co-authored papers
1
Christopher E Barbieri
Weill Cornell Medical College
Co-authored papers
1
Bishoy F Faltas
Englander Institute for Precision Medicine
Co-authored papers
1
Sinan Ramazanoglu
Englander Institute for Precision Medicine
Co-authored papers
1
Juan Miguel Mosquera
Caryl and Israel Englander Institute for Precision Medicine
Co-authored papers
1
1 - 30